These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 4038390)

  • 1. Clinical pharmacology of intraperitoneal cisplatin.
    Lopez JA; Krikorian JG; Reich SD; Smyth RD; Lee FH; Issell BF
    Gynecol Oncol; 1985 Jan; 20(1):1-9. PubMed ID: 4038390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ip cisplatin in patients with malignant ascites: pharmacokinetic evaluation and comparison with the iv route.
    Casper ES; Kelsen DP; Alcock NW; Lewis JL
    Cancer Treat Rep; 1983 Mar; 67(3):235-8. PubMed ID: 6682012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics study of intraperitoneal cisplatin in ovarian carcinoma].
    Han GR; Cai GF
    Zhonghua Fu Chan Ke Za Zhi; 1993 Apr; 28(4):224-6, 254. PubMed ID: 8404307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High doses of intrapleural cisplatin in a case of malignant pleural mesothelioma. Clinical observations and pharmacokinetic analyses.
    Lerza R; Esposito M; Vannozzi M; Bottino GB; Bogliolo G; Pannacciulli I
    Cancer; 1994 Jan; 73(1):79-84. PubMed ID: 8275441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional pharmacokinetic selectivity of intraperitoneal cisplatin in ovarian cancer.
    Esposito M; Campora E; Repetto M; Fulco RA; Simoni GA; Falcone A; Collecchi P; Gogioso L; Nobile MT; Civalleri D
    Oncology; 1988; 45(2):69-73. PubMed ID: 3353075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of cis-dichlorodiammineplatinum.
    Gormley PE; Bull JM; LeRoy AF; Cysyk R
    Clin Pharmacol Ther; 1979 Mar; 25(3):351-7. PubMed ID: 761445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of total and free cisplatin on two consecutive treatment cycles in patients with ovarian cancer.
    Erlichman C; Soldin SJ; Thiessen JJ; Sturgeon JF; Fine S
    Cancer Chemother Pharmacol; 1987; 19(1):75-9. PubMed ID: 3815729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of intra-arterial and intravenous cisplatin in head and neck cancer patients.
    Gouyette A; Apchin A; Foka M; Richard JM
    Eur J Cancer Clin Oncol; 1986 Mar; 22(3):257-63. PubMed ID: 3709595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effective treatment of peritoneal carcinosis by intraperitoneal cis-diamminedichloroplatinum (c-DDP) administration with systemic sodium thiosulfate protection. Clinical results and pharmacokinetics].
    Rückle H; Ehninger G; Jakob F; Wilms K
    Klin Wochenschr; 1986 May; 64(10):467-74. PubMed ID: 3723994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis.
    Tempfer CB; Hilal Z; Dogan A; Petersen M; Rezniczek GA
    Eur J Surg Oncol; 2018 Jul; 44(7):1112-1117. PubMed ID: 29753612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetic study of intraperitoneal chemotherapy with high-dose cisplatin for advanced ovarian cancer].
    Deng C; Huang R; Lian L
    Zhonghua Fu Chan Ke Za Zhi; 1996 Mar; 31(3):159-62. PubMed ID: 8758790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy.
    Los G; Verdegaal EM; Mutsaers PH; McVie JG
    Cancer Chemother Pharmacol; 1991; 28(3):159-65. PubMed ID: 1855272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin administered as a continuous 5-day infusion: plasma platinum levels and urine platinum excretion.
    Belliveau JF; Posner MR; Ferrari L; Crabtree GW; Cummings FJ; Wiemann MC; O'Leary GP; Griffin H; Phaneuf MA; O'Rourke A
    Cancer Treat Rep; 1986 Oct; 70(10):1215-7. PubMed ID: 3756943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of carboplatin.
    Oguri S; Sakakibara T; Mase H; Shimizu T; Ishikawa K; Kimura K; Smyth RD
    J Clin Pharmacol; 1988 Mar; 28(3):208-15. PubMed ID: 3283185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced ability to clear ultrafilterable platinum with repeated courses of cisplatin.
    Reece PA; Stafford I; Russell J; Gill PG
    J Clin Oncol; 1986 Sep; 4(9):1392-8. PubMed ID: 3746376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and intraperitoneal pharmacokinetics of cisplatin within intraoperative intraperitoneal chemotherapy: influence of protein binding.
    Royer B; Guardiola E; Polycarpe E; Hoizey G; Delroeux D; Combe M; Chaigneau L; Samain E; Chauffert B; Heyd B; Kantelip JP; Pivot X
    Anticancer Drugs; 2005 Oct; 16(9):1009-16. PubMed ID: 16162978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Test dose-guided administration of cisplatin in an anephric patient: a case report.
    Ribrag V; Droz JP; Morizet J; Leclercq B; Gouyette A; Chabot GG
    Ann Oncol; 1993 Sep; 4(8):679-82. PubMed ID: 8240999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-tissue and plasma concentrations of platinum during chemotherapy of non-small-cell lung cancer patients.
    Pujol JL; Cupissol D; Gestin-Boyer C; Bres J; Serrou B; Michel FB
    Cancer Chemother Pharmacol; 1990; 27(1):72-5. PubMed ID: 2173980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I clinical and pharmacological study of intraperitoneal cis-bis-neodecanoato( trans- R, R-1, 2-diaminocyclohexane)-platinum II entrapped in multilamellar liposome vesicles.
    Verschraegen CF; Kumagai S; Davidson R; Feig B; Mansfield P; Lee SJ; Maclean DS; Hu W; Khokhar AR; Siddik ZH
    J Cancer Res Clin Oncol; 2003 Oct; 129(10):549-55. PubMed ID: 14513369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic evidence for an enterohepatic circulation in a patient treated with cis-dichlorodiammineplatinum (II).
    Vermorken JB; van der Vijgh WJ; Pinedo HM
    Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):319-28. PubMed ID: 7190316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.